Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 4/20 | 0.38 |
| ▸ | EPOR | P19235 | 4/20 | 0.38 |
| ▸ | NPY1R | P25929 | 2/20 | 0.37 |
| ▸ | NPY4R | P50391 | 2/20 | 0.37 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.37 |
| ▸ | GLP1R | P43220 | 4/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27291550 | 0.93 | FURIN (0.36) | FURINEPORSIRT5GLP1R | |
| SCHEMBL27291562 | 0.91 | FURIN (0.37) | FURINEPORSIRT5 | |
| SCHEMBL24864407 | 0.90 | FURIN (0.39) | FURINNPY1RNPY4RSIRT5 | |
| SCHEMBL27291543 | 0.89 | FURIN (0.35) | FURINEPORGLP1RRXFP1 | |
| SCHEMBL29340094 | 0.85 | FURIN (0.34) | FURINEPORNPY1RNPY4RRXFP1 | |
| SCHEMBL21897658 | 0.85 | NPY4R (0.40) | FURINNPY1RNPY4RSIRT5 | |
| SCHEMBL29345967 | 0.84 | FURIN (0.36) | FURINNPY1RNPY4R | |
| SCHEMBL24864529 | 0.83 | FURIN (0.34) | FURINEPORNPY1RNPY4R | |
| SCHEMBL24864452 | 0.83 | FURIN (0.35) | FURINSIRT5 | |
| SCHEMBL24864398 | 0.83 | FURIN (0.35) | FURINSIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207429-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207429-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PAICS, DHFR, CD44 | FURIN 34/4885EPOR 983/4885NPY1R 4170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.